Function Health emphasized its positioning as a data-driven preventive health platform, spotlighting a panel of more than 160 lab tests that include extensive metabolic and hormonal markers, and offering optional MRI and CT imaging as part of its diagnostics strategy.
Recent communications focused on insulin, cortisol, thyroid hormones and leptin in weight management, framing stalled progress despite lifestyle changes as a potential sign of underlying biomarker imbalances; the company claims that insulin testing, alongside glucose, can detect metabolic risk earlier than standard blood work.
Function Health referenced medical experts Dan Sodickson, M.D., PhD, and Mark Hyman, M.D., in its materials and linked lifestyle factors such as time in blue spaces and seasonal vitamin D shifts to specific lab markers to encourage engagement and repeat testing.
The company consistently labeled materials as marketing rather than medical advice, reflecting attention to regulatory boundaries. The developments underscore a push toward recurring revenue through longitudinal health monitoring and a clinically framed diagnostics offering.
